Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
37.93
+0.33 (0.88%)
Mar 30, 2026, 1:48 PM EDT - Market open
Corcept Therapeutics Employees
Corcept Therapeutics had 730 employees as of December 31, 2025. The number of employees increased by 230 or 46.00% compared to the previous year.
Employees
730
Change (1Y)
230
Growth (1Y)
46.00%
Revenue / Employee
$1,043,023
Profits / Employee
$134,481
Market Cap
4.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 730 | 230 | 46.00% | 730 | 0 |
| Dec 31, 2024 | 500 | 148 | 42.05% | 500 | 0 |
| Dec 31, 2023 | 352 | 53 | 17.73% | 352 | 0 |
| Dec 31, 2022 | 299 | 61 | 25.63% | 299 | 0 |
| Dec 31, 2021 | 238 | 2 | 0.85% | 238 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| CRISPR Therapeutics AG | 393 |
| Centessa Pharmaceuticals | 114 |
| Erasca | 103 |
| Spyre Therapeutics | 102 |
| NewAmsterdam Pharma Company | 100 |
CORT News
- 1 day ago - Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session - Business Wire
- 5 days ago - Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer - Reuters
- 5 days ago - FDA Approves Corcept's Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian Cancer - Business Wire
- 6 days ago - Shareholders who lost money in shares of Corcept Therapeutics (NASDAQ: CORT) should contact Wolf Haldenstein immediately - PRNewsWire
- 11 days ago - Robbins LLP Urges CORT Stockholders to Contact the Firm for Information About the Class Against Corcept Therapeutics Incorporated - PRNewsWire
- 18 days ago - Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 19 days ago - REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026 - Business Wire
- 20 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Corcept Therapeutics Incorporated Lawsuit - CORT - PRNewsWire